Alzheimer’s Therapeutics market is projected to grow at a CAGR of 9.17% by 2032: Visiongain Reports Ltd
January 19, 2023 11:45 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Alzheimer’s Therapeutics 2022-2032. It includes profiles of Alzheimer’s Therapeutics and Forecasts Market Segment by Drug (Donepezil, Rivastigmine,...
The Stem Cell Technologies and Applications market is projected to grow at a CAGR of 8.9% by 2032: Visiongain Reports Ltd
January 10, 2023 06:36 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Stem Cell Technologies and Applications 2022-2032. It includes profiles of Stem Cell Technologies and Applications and Forecasts Market Segment by Type,...
Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd
January 09, 2023 09:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Macular Degeneration (AMD) and Other Retinal Diseases Drugs 2022-2032. It includes profiles of Macular Degeneration (AMD) and Other Retinal Diseases...
Antiviral drugs market is projected to grow at a CAGR of 3.49% by 2032: Visiongain Reports Ltd
January 09, 2023 06:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Antiviral Drugs 2022-2032. It includes profiles of Antiviral Drugs and Forecasts Market Segment by Drug Class (DNA Polymerase Inhibitors, Reverse...
Asthma & COPD Therapies market is projected to grow at a CAGR of 7.31% by 2033: Visiongain Reports Ltd
January 03, 2023 11:56 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Asthma & COPD Therapies 2023-2033. It includes profiles of Asthma & COPD Therapies and Forecasts Market Segment by Product (Anti-inflammatory...
Global HIV and HBV Therapies market is projected to grow at a CAGR of 6.5% by 2032: Visiongain Reports Ltd
December 30, 2022 06:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Global HIV and HBV Therapies Market. It includes Market Segment by Drug Class (Combination Therapies, Nucleoside and Non-nucleoside RTIs, Integrase...
Dermatology Drugs market is projected to grow at a CAGR of 6.2% by 2032: Visiongain Reports Ltd
December 29, 2022 09:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Dermatology Drugs 2022-2032. It includes profiles of Dermatology Drugs and Forecasts Market Segment by Disease (Psoriasis, Dermatitis, Acne, Skin...
Antisense Oligonucleotide Therapeutics market is projected to grow at a CAGR of 13.71% by 2032: Visiongain Reports Ltd
December 23, 2022 09:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Antisense Oligonucleotide Therapeutics 2022-2032. It includes profiles of Antisense Oligonucleotide Therapeutics and Forecasts Market Segment by...
OTC Drugs & Dietary Supplements market is projected to grow at a CAGR of 7.90% by 2032: Visiongain Reports Ltd
December 22, 2022 09:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled OTC Drugs & Dietary Supplements 2022-2032. It includes profiles of OTC Drugs & Dietary Supplements and Forecasts Market Segment by Category...
Respiratory Inhalers market is projected to grow at a CAGR of 8.02% by 2033: Visiongain Reports Ltd
December 15, 2022 05:29 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Respiratory Inhalers 2023-2033. It includes profiles of Respiratory Inhalers and Forecasts Market Segment by Product Type (Standard Pressurized...